Skip to content

Clinical trials

Coronavirus Infections trials in China with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronavirus Infections Status: Unknown status Country / region: China Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
202010
20211
20222
20234

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.3
Qilu Hospital of Shandong University2
Shanghai Public Health Clinical Center2
Third Affiliated Hospital, Sun Yat-Sen University2
China National Biotec Group Company Limited1
Frontier Biotechnologies Inc.1
Nanfang Hospital, Southern Medical University1
Peking University Third Hospital1
Ruijin Hospital1
Second Affiliated Hospital, Zhejiang University, School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronavirus Infections17
COVID-193
Pneumonia2
Critical Illness1
Dyspnea1
Lung Neoplasms1
Pneumonia, Pneumocystis1
Post-Acute COVID-19 Syndrome1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.